Welcome to MeTA
Medicines Transparency Alliance (MeTA) is a multi-stakeholder alliance working to improve access and affordability of medicines for the one-third of the world’s population unable to access essential medicines due to high cost or local unavailability.
The Benefits of MeTA:
- Promotes transparency
- Generates accountability
- Increases collaboration
- Encourages equity
- Improves efficiency
- Advocates for access to medicines
Australia to provide better access to prescription medicine information
Australia makes prescription medicine product information and consumer medicine information available on Therapeutic Goods Administration website.
Distributing medicine worldwide
Panel considers McGill’s collaborative role in global accessibility initiatives
Pharma manufacturers in Ghana
Calls on the Government to adopt measures to develop the capacity of local pharma companies and help improve access to medicines.
Baseline data collection for the MeTA process
Collecting data about access to medicines and multi-stakeholder processes is a critical component of MeTA
Assessing the baseline pharmaceutical sector situation in MeTA pilot countries
As MeTA triggers lasting advances in access to medicines, evaluation tools continue to play a crucial role
- Prices
The most effective medicines in the world are useless if they are priced too high - Quality
When you take your pill, you want to be sure that it is of good quality - Availability
One in every three people in the world does not have the basic medicines they need - Promotion
Medicines' promotion to agencies, professionals and users should adhere to strict ethical standards - Transparency & accountability
Information is power – if it is acted on - Multi-stakeholder working
Bringing together the people and organisations that can make change, that can be held to account and hold others to account
Australia to provide better access to prescription medicine information
Australia makes prescription medicine product information and consumer medicine information available on Therapeutic Goods Administration website.
Distributing medicine worldwide
Panel considers McGill’s collaborative role in global accessibility initiatives
Pharma manufacturers in Ghana
Calls on the Government to adopt measures to develop the capacity of local pharma companies and help improve access to medicines.
Baseline data collection for the MeTA process
Collecting data about access to medicines and multi-stakeholder processes is a critical component of MeTA